Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Late pulmonary toxicity of bleomycin.

Willenbacher W, Mumm A, Bartsch HH.

J Clin Oncol. 1998 Sep;16(9):3205. No abstract available.

PMID:
9738596
2.

[Bleomycin-induced pneumonia].

Berger K, Göpfert A, Berkel H.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1996 Nov;31(9):577-81. German.

PMID:
9063925
3.

Bleomycin lung: the effect of different chemotherapeutic regimens.

Chisholm RA, Dixon AK, Williams MV, Oliver RT.

Cancer Chemother Pharmacol. 1992;30(2):158-60.

PMID:
1376217
4.

Flagellate erythema secondary to bleomycin.

Khaliq W, Antonarakis ES.

QJM. 2012 Sep;105(9):901. doi: 10.1093/qjmed/hcr150. No abstract available.

PMID:
21865305
5.
6.

Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study.

Herlofson BB, Norman-Pedersen K, Redfors M, Fosså SD.

Eur J Oral Sci. 1997 Oct;105(5 Pt 2):523-6.

PMID:
9395118
7.

Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy.

Andrade RS, Kesler KA, Wilson JL, Brooks JA, Reichwage BD, Rieger KM, Einhorn LH, Brown JW.

Ann Thorac Surg. 2004 Oct;78(4):1224-8; discussion 1228-9. Review.

PMID:
15464475
8.
10.

[Treatment of advanced testicular cancer and toxicity of chemotherapy].

Kawakita M, Matsuda T, Terachi T, Yoshida O.

Hinyokika Kiyo. 1999 Nov;45(11):783-6. Japanese.

11.

Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.

Hinton S, Catalano PJ, Einhorn LH, Nichols CR, David Crawford E, Vogelzang N, Trump D, Loehrer PJ Sr.

Cancer. 2003 Apr 15;97(8):1869-75.

12.

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.

Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C; German Testicular Cancer Study Group..

J Clin Oncol. 2003 Nov 15;21(22):4083-91.

PMID:
14568987
13.

POMB/ACE chemotherapy for mediastinal germ-cell tumours.

Droz JP.

Eur J Cancer. 1997 May;33(6):809-11. No abstract available.

PMID:
9291797
14.

Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.

Sleijfer S, van der Mark TW, Schraffordt Koops H, Mulder NH.

Eur J Cancer. 1996 Mar;32A(3):550-2.

PMID:
8814706
15.

Chemotherapy for good-risk germ-cell tumors.

Ryan CJ, Bajorin DF.

Semin Urol Oncol. 2002 Nov;20(4):244-50. Review.

PMID:
12489057
16.
17.

Bleomycin and scuba diving: to dive or not to dive?

Huls G, ten Bokkel Huinink D.

Neth J Med. 2003 Feb;61(2):50-3.

18.

History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.

Sweeney C.

Semin Urol Oncol. 2001 Aug;19(3):170-9. Review.

PMID:
11561984
19.

Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer.

Kawai K, Akaza H.

Expert Opin Drug Saf. 2003 Nov;2(6):587-96. Review.

PMID:
14585067
20.

Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease.

Real E, Roca MJ, Viñuales A, Pastor E, Grau E.

Haematologica. 1999 Jul;84(7):667-8. No abstract available.

Supplemental Content

Support Center